Curis Lifesciences Limited (NSE:CURIS)

India · Delayed Price · Currency is INR

165.70

+14.35 (9.48%)

At close: Sep 7, 2026

Curis Lifesciences Financials Overview

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Revenue	606.29	606.29	496.32	355.56	354.49	237.45
Revenue Growth	155.33%	22.16%	39.59%	0.30%	49.29%	11.69%
Gross Profit	187.13	187.13	143.18	124.31	70.53	79.63
Operating Income	104.34	104.34	93.63	77.11	31.8	28.26
Net Income	69.16	69.16	61.05	48.67	18.75	4.92
Earnings Per Share	10.26	10.26	10.29	8.26	3.18	0.90
EPS Growth	1046.02%	-0.27%	24.61%	159.53%	255.33%	-3.17%

Revenue by Geography

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
India	477.88	340.56	333.7	72.48
Export	0.13	2	3.56	-
Other	13.31	13	17.23	-
Total	491.32	355.56	354.49	213.8

Cash & Debt

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Investments	31.65	31.65	3.04	4.18	1.52	1.11
Total Debt	215.91	215.91	156.18	170.89	161.93	176.24
Net Cash (Debt)	-184.26	-184.26	-153.14	-166.72	-160.41	-175.13
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-27.33	-27.33	-25.81	-28.28	-27.21	-31.84

Cash Flow & CapEx

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Operating Cash Flow	-164.16	-164.16	-17.63	2.8	33.55	49.46
Capital Expenditures	-18.02	-18.02	-0.93	-0.73	-6.23	-3.99
Free Cash Flow	-182.18	-182.18	-18.56	2.07	27.31	45.47
Free Cash Flow Growth	-	-	-	-92.42%	-39.93%	-

Margins

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Gross Margin	30.86%	30.86%	28.85%	34.96%	19.90%	33.53%
Operating Margin	17.21%	17.21%	18.86%	21.69%	8.97%	11.90%
Pretax Margin	15.77%	15.77%	16.66%	20.17%	6.18%	5.17%
Profit Margin	11.41%	11.41%	12.30%	13.69%	5.29%	2.07%
FCF Margin	-30.05%	-30.05%	-3.74%	0.58%	7.70%	19.15%

Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep '26 Sep 8, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
PE Ratio	16.15	10.87	-	-	-	-
PS Ratio	2.21	1.24	-	-	-	-